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Background: Thoracic sympathectomy is used in the management of a variety of upper limb disorders. We have analyzed
the evidence for thoracic sympathectomy in the management of digital ischemia.
Methods:We reviewed the English literature between 1980 and 2010. Our analysis included reports with the clinical end
points of relief, recurrence of symptoms or healing of ulcers, or both. Primary Raynaud disease (PRD) and secondary
Raynaud phenomenon (SRP) were analyzed separately.
Results: An initial postoperative positive effect was reported in 92% of PRD patients and in 89% of SRP patients.
Long-term beneficial effect was 58% for PRD and 89% for SRP. Ulcer healing or improvement was achieved in 95%.
Conclusions: The available evidence suggests that thoracic sympathectomy has a role in the treatment of severe PRD and
SRP, albeit with better results in SRP patients than in PRD patients. In case of digital ulceration, thoracic sympathectomy
may maximize tissue preservation or prevent amputation. (J Vasc Surg 2011;54:273-7.)
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sReports of the long-term effects of thoracic sympathec-
tomy (TS) or endoscopic thoracic sympathectomy (ETS),
or both, in the management of upper limb ischemia
are inconsistent, resulting in the lack of consensus and
evidence-based recommendations regarding this surgical
intervention.1-3 This article provides an overview of the
available evidence in the international literature.
METHODS
We systematically reviewed the English literature be-
tween 1980 and 2010 using a Medline and Embase search.
Keywords used were digital, finger, upper limb, hand,
ischemia, vascular occlusive disease, Raynaud, ulcer, em-
boli, Buerger, and sympathectomy. We also examined the
Cochrane database and reference lists of relevant studies.
Studies lacking clinical end points of relief, or recurrence of
symptoms or healing of ulcers, or both, were excluded.
Systematic reviews, small case series (n 5), and letters to
the editors were also excluded. Owing to potential differ-
ences in outcomes between the underlying disorders, we
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doi:10.1016/j.jvs.2011.01.069ivided the patients into two groups—primary Raynaud
isease (PRD) and secondary Raynaud phenomenon
SRP)—and analyzed them separately.
ESULTS
We included 13 retrospective and 5 prospective stud-
es.4-21 There were no randomized controlled trials. One
tudy was randomized but lacked a control group.11 One
rticle provided data on ulcer healing only.14 A total of
28 procedures were performed on 580 patients with
pper limb ischemia. Short-term follow-up data for relief
r recurrence of symptoms were available for 469 proce-
ures and long-term follow-up data for 399 procedures.
utcomes of 123 patients with ulcerations could be
nalyzed.
PRD. Nine studies reported outcomes of ETS and TS
or PRD. A total of 155 procedures were performed in 114
atients. Postoperative data were available for 151, and
ong-term results were available for 111 procedures. Initial
mprovement after ETS was reported in 92% and long-term
enefits in 58%. ETS was unsuccessful in alleviating symp-
oms in 42% of procedures (Table I).
SRP. Outcomes of TS and ETS for SRP were reported
n 17 articles, comprising 511 procedures in 449 patients.
ostoperative data were available for 318, long-term results
or 288 procedures. Initial improvement after TS and ETS
as experienced by 89% of patients. Although the number
f patients with an excellent effect decreased, there was a
ustained improvement in 89% of procedures at the end of
ollow-up (Table II).
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in 12 studies comprising 123 patients. All studies re-
ported an overall positive effect. Ulcer healing was
achieved in 81%, improvement in 14%, and sympathec-
tomy had no effect in 2% (Table III). Even when the
ulcerations did not completely heal, there was good
demarcation of the necrotic areas that allowed maximal
preservation of viable tissue.8,14
Complications and side effects. Table IV reports the
total incidence of adverse effects of surgical sympathectomy
Table I. Clinical outcome of thoracic sympathectomy (TS
Study, year
(First author)
Procedures
(Patients) Type Mean FU(ran
Prospective studies
Claes,7 1994 18 (9)a ETS NA (4-48 months)
Magneas,16 1987 13 (10) TS 3,9 years (1-5 years
Retrospective studies
Thune,18 2006 19 (19)b ETS 40 months (7-114
Matsumoto,17 2002 20 (20)b ETS 62.5 months (NA)
Cartier,5 1999 5 (4)a ETS NA (NA)
Claes,6 1993 7 (7) ETS NA (24-60 months
Adams,4 1992 12 (6) ETS 13 months (1-20 m
Van de Wal,19 1985 35 (25) TS 8.9 years (2-16 yea
Welch,20 1984 26 (14)a TS NA (up to 17 years
Totals, No. (%) 155 (114)
B, Better; E, excellent or symptom free; ETS, endoscopic thoracic sympathe
aOutcomes given in number of patients, if possible converted to number of
bTotal number of procedures available, not specified for primary and second
Table II. Clinical outcome of patients with secondary Ray
Study, year
(First author)
Procedures
(Patients) Type
Mean FU
(range)
Prospective studies
El-Samadoni,10 2010 11 (11) ETS 4.7 days (3-8 days)
Gabrhelik,11 2009 50 (50)a PTS At 7 days and 90 days
Khan,13 2008 17 (17)a TS NA (up to 48 months)
Claes,7 1994 10 (5)b ETS NA (4-48 months)
Magneas,16 1987 24 (24) TS 3.9 years (1-5 years)
Retrospective studies
Thune,18 2006 15 (15)c ETS 40 months (7-114 mo
Matsumoto,17 2002 8 (8)c ETS 62.5 months (NA)
De-Giacomo,8 2002 20 (15)b ETS 33 months (3-71 mon
Cartier,5 1999 6 (6) ETS NA (NA)
Claes,6 1993 5 (5) ETS NA (24-60 months)
Adams,4 1992 2 (2) ETS At 18 months and 25 m
Van de Wal,19 1985 36 (31) TS 8.4 years (1-14 years)
Dunant,9 1985 42 (36)b TS NA (8-12 months)
Welch,20 1984 18 (14) TS NA (up to 17 years)
Gahhos,12 1984 8 (8)a TS NA (up to120 months
Linder,15 1983 150 (129) TS NA (12-180 months)
Welling,21 1981 89 (73) TS NA (NA)
Totals, No. (%) 511 (449)
B, Better; E, excellent or symptom free; ETS, endoscopic thoracic sympat
thoracic sympathectomy; S, same; TS, thoracic sympathectomy; W, worse.
aNumber of procedures not available, presumed as unilateral in all patients.
bOutcomes given in number of patients, converted if possible to number of
cTotal number of procedures available, not specified for primary Raynaud aof the 18 included studies. Two studies did not show any pdverse effects,7,14 Others reported that almost all patients
xperienced side effects.17,21 Although side effects fre-
uently occurred, most patients found them only a minor
uisance and did not regret the operation4,6
ISCUSSION
Maurice Raynaud published his thesis “Local asphyxia
nd symmetrical gangrene of the extremities” in 1862. He
escribed a condition triggered by cold or emotional stress
haracterized by a typical tricolor phenomenon consisting of a
primary Raynaud disease
Short-term FU (18 months)
NA E B S W
0 18 0 0 0
0 13 0 0 0
hs) 4 10 1 4 0
0 18 1 1 0
0 5 0 0 0
0 7 0 0 0
s) 0 2 9 1 0
0 0 31 4 0
0 0 26 0 0
4 73/151 (49) 68/151 (43) 10/151 (8) 0 (0)
; FU, follow-up; NA, not available; S, same; W, worse.
dures.
aynaud separately; therefore, assumed as unilateral.
phenomenon
Short-term FU (18 months)
NA E B S W
0 6 4 1 0
0 40 3 7 0
0 16 0 1 0
0 10 0 0 0
0 22 1 0 1
0 8 6 1 0
0 7 0 1 0
0 0 20 0 0
0 6 0 0 0
0 5 0 0 0
s 0 1 1 0 0
0 0 33 3 0
42 NA NA NA NA
1 8 4 5 0
0 5 3 0 0
150 NA NA NA NA
0 0 74 15 0
193 134/318 (42) 149/318 (47) 34/318 (11) 1/318 (1)
y; FU, follow-up; NA, not available; PTS, percutaneous radiofrequency
dures
ondary Raynaud separately, therefore assumed as unilateral.) for
ge)
)
mont
)
onth
rs)
)
ctomynaud
nths)
ths)
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)
hectomale, cyanotic, and hyperemic phase.22 Thomas Lewis further
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pathic, and SRP is related to an underlying disease. We found
a widely diverse array of terms to define the disorders that
cause ischemia of the upper extremity.We advocate the use of
the Lewis classification to improve uniformity.
We found five prospective studies. One study was ran-
domized, but did not have a control group.11 The remain-
ing studies were retrospective. There is a need for random-
ized controlled trials to provide more solid, evidence-based
recommendations. Three studies mentioned the number of
Table I. Continued
Long-term F
NA E B
0 0 6
0 2 11
19 NA NA
0 5 14
1 2 0
0 0 2
12 NA NA
4 0 18
8 0 4
44 9/111 (8) 55/111 (
Table II. Continued
Long-term F
NA E B
11 NA NA
50 NA NA
1 11 4
0 10 0
0 20 4
15 NA NA
0 0 6
5 6 6
0 4 0
0 4 0
0 1 1
10 0 20
6 28 8
6 3 5
0 1 0
30 0 113
89 NA NA
223 88/288 (31) 167/28patients included but did not indicate the total number of rrocedures, and we assumed all procedures were unilate-
al.11-13 Five articles described the outcomes for the total of
atients, rather than procedures. If conversion to the total
f procedures was impossible, we assumed that they were all
nilateral. In 9 of 18 reviewed studies, a thoracoscopic
pproachwas performed; in 8 studies, the sympathetic chainwas
emoved through an open technique, and in 1 study percutane-
us radiofrequency sympathectomy was performed.
The extent of sympathectomy differed substantially
mong the reviewed articles, ranging cranially from the gray
18 months)
S W
12 0
0 0
NA NA
1 0
2 0
5 0
NA NA
12 1
14 0
46/111 (41) 1/111 (1)
18 months)
S W
NA NA
NA NA
1 0
0 0
0 0
NA NA
1 1
3 0
2 0
1 0
0 0
4 2
0 0
4 0
7 0
5 2
NA NA
) 28/288 (10) 5/288 (2)U (
50)U (
8 (58ami of C6 to caudally T5.5,16 Nevertheless, most authors
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studies pointed out that the second and third thoracic ganglia
are responsible for the sympathetic innervation of the hand
and that an extension of the sympathectomy beyond these
ganglia provided no additional benefit in obtaining the de-
sired reduction of the sympathetic tone of the hand.24,25
Three series reported sympathectomy in addition to
other interventions. Dunant9 performed a first rib resection
and thereafter a TS. Magneas16 combined a similar surgical
Table III. Ulcer healing
Study, year
(First author)
Procedures
(Patients) Type Mean FU (ra
Prospective studies
Gabrhelik,11 2009 50 (50)a PTS At 7 and 90 days
Khan,13 2008 17 (17)a TS NA (up to 48 mon
Claes,7 1994 28 (14) ETS NA (4-48 months
Magneas,16 1987 37 (34) TS 3.9 years (1-5 year
Retrospective studies
Thune,18 2006 52 (34) ETS 40 months (7-114
Lee,14 2006 18 (17) ETS NA (6-72 months
Matsumoto,17 2002 54 (28) ETS 62.5 months (NA)
De-Giacomo,8 2002 20 (15) ETS 33 months (3-71 m
Cartier,5 1999 11 (10) ETS NA (NA)
Claes,6 1993 12 (12) ETS NA (24-60 month
Dunant,9 1985 42 (36) TS NA (8-12 months
Welch,20 1984 44 (28) TS NA (up to 17 year
Totals, No. (%) 385 (295)
ETS, Endoscopic thoracic sympathectomy; FU, follow-up;NA, not available; PTS,
aNumber of procedures not available, presumed as unilateral in all patients.
Table IV. Complications and adverse effects
Outcome
TS
(n  430)
ETS
(n  713)
PTS
(n  50)
Thorax: conservativea 42 16 0
Thorax: interventionb 26 8 1
Neurologic: transientc 48d 12 0
Neurologic: permanente 59d 4 0
Compensatory sweating NAf 307 0
Wound healing disordersg 45 0 0
Rib fracture 2 0 0
Atrial fibrillation 0 1 0
Dry hands 0 17 0
Stuffy nose 7 0 0
ETS, Endoscopic thoracic sympathectomy; PTS, percutaneous radiofre-
quency thoracic sympathectomy; TS, thoracic sympathectomy.
aPneumothorax, pleural effusion, pneumonia, atelectasis; treatment: conser-
vative and medication.
bPneumothorax, hemothorax, pleural effusion; treatment: thoracocentesis,
drainage, or rethoracotomy.
cHorner syndrome, neuralgia, diaphragm/phrenic nerve paresis, eyelid
droop, vocal cord paralysis.
dLinder15 reported Horner syndrome in almost all patients; however, no
number of patients available.
eHorner syndrome, phrenic nerve paresis/paralysis, neuralgia, scapula alata,
eyelid droop, vocal cord paralysis.
fNA, not available: studies report compensatory sweating without giving an
objective number or percentage.
gWound infection or wound healing disorders not otherwise specified.intervention, a neurovascular decompression, with TS. El- camadoni et al10 designed a five-stage intervention proto-
ol for intra-arterial recreational drug injection users, who
ere included in the study.
Follow-up ranged from 3 days to 17 years. Eight arti-
les did not provide the mean follow-up, and one study did
ot mention the range of follow-up. Data collection with
bjective measurements was obtained in nine reports. Six
eries used Doppler technology, thermographic equip-
ent, standardized questionnaires, or visual analog scales.
n three articles, frequency of oral analgesics intake or
requency of vasospastic attacks were assessed. The other
tudies did not describe the method of postoperative data
ollection. In two series, when the patients’ palms were
oted to be warm and dry postoperatively, this was taken as
ufficient evidence to claim a satisfactory clinical response
o sympathectomy. Obviously, these subjective end points
onstitute a major risk for interpretive bias.
Another major point of discussion is the conflicting pre-
entation of adverse effects. Claes7 and Lee et al14 reported no
ostoperative adverse affects, whereas compensatory sweating
as reported in up to 86% of cases byMatsumoto et al,17 and
lmost all patients acquired Horner syndrome in Welch’s
ublication.20 We can only assume that adverse effects were
ot a main focus in some reports and therefore were under-
eported. This is supported by a recent literature review re-
orting compensatory sweating in 45% to 98.6% of cases and
orner syndrome in 0% to 6.9%.26 Most authors described
he total number of adverse effects without distinguishing
etween the indication for surgical sympathectomy. Our out-
omes concerning the adverse effects are therefore the combined
ata of all included patients and procedures of the 18 studies.
The long-term effect of TS and ETS in the manage-
ent of PRD is heavily debated. All of the reviewed articles
eported a decrease in effect over time, with a recurrence of
ymptoms in almost all patients. Recurrence of symptoms
ypically begins at 6 months after sympathectomy. The
No. of patients with
Ulceration Healing Improved No effect No data
3 3 0 0 0
11 10 0 1 0
5 5 0 0 0
11 11 0 0 0
ths) 8 8 0 0 0
12 4 7 1 0
7 7 0 0 0
hs) 11 5 6 0 0
6 0 4 0 2
5 5 0 0 0
36 36 0 0 0
8 6 0 0 2
123 100 (81) 17 (14) 2 (2) 4 (3)
aneous radiofrequency thoracic sympathectomy; TS, thoracic sympathectomy.nge)
ths)
)
s)
mon
)
ont
s)
)
s)ause of this loss of effect is debated: incomplete surgical
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1
1
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1
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ways, or hypersensitivity of the noradrenergic receptors
regulating the precapillary sphincters reacting on very small
amounts of circulating catecholamines have all been impli-
cated as factors precipitating recurrence of symptoms.2,17
We found an excellent long-term effect in 8% of patients
with PRD, and another 50% of the operated-on patients
claimed a beneficial effect of sympathectomy. Although the
positive effects were marginal, none of the patients regretted
the surgical intervention.4,7 The long-term effect of TS is
better in patients operated-on for SRP, with 31% having
excellent results and 58% having a beneficial effect. This dif-
ference with PRD could be explained by the more objective
end points for patients with SRP (tissue loss and ulcers) vs the
more subjective end points of pain and the tricolor phenom-
enon inmost patients with PRD, because complete healing or
significant improvement was achieved in 95% of the patients
treated for digital ulceration. In line with this hypothesis,
Maga et al27 and Leesman et al28 reported a discrepancy
between patient symptoms and objectivelymeasured variables
regarding PRD. Another explanation is that sympathectomy
for SRP is frequently performed after tissue loss due to embo-
lization or thrombosis of digital arteries, whereby temporary (6
months) vasodilatationof the skin arterioles apparently enhanced
the tissue oxygenation enough forwoundhealing. After healing,
less oxygenation is required, and an increase in sympathetic tone
has no clinical consequences on the healed wound.
CONCLUSIONS
Despite the many shortcomings in study design, lack of
uniformity in terminology and surgical procedures, and ab-
sence of hard endpoints, there seem tobe benefits of TS in the
setting of upper extremity ischemia. In particular, in the man-
agement of digital skin ulceration, maximizing tissue preser-
vation, or prevention of amputation was frequently reported.
TS appears to have solid long-term results in the treatment of
SRP, contrary to PRD, where the benefit inmost patients was
limited to the first 6 months postoperatively. Nevertheless,
due to theminimal invasiveness and low reported incidence of
major complications or adverse effects, TS remains a therapeu-
tic option in the treatment of severe PRD and SRP.
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